Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Common Stock | Options Exercise | $1.04M | +23.9K | +29.65% | $43.50 | 104K | Feb 14, 2024 | Direct | |
transaction | XYL | Common Stock | Sale | -$2.93M | -23.9K | -22.87% | $122.55 | 80.5K | Feb 14, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -23.9K | -50% | $0.00 | 23.9K | Feb 14, 2024 | Common Stock | 23.9K | $43.50 | Direct | F2 |
Id | Content |
---|---|
F1 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 23,870 Shares were executed at a range of prices from $122.45 to $123.4499. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
F2 | The April 2, 2018 option grant vested one fourth on January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022. |